StockData
Tevogen Inc. logo

Tevogen Inc. (TVGN) stock

TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$6.14+0.45 (+7.91%)

Close on Nov 18, 2026Market cap $39.98MP/E –Yield –

Tevogen pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Tevogen's pe ratio was 5.9× on Apr 28, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 20235.9×–

More Tevogen figures

See a number that looks wrong?